Valiant Laboratories Ltd. (VALIANTLAB) 52 Week High Streak: Second Straight Session Near Peak

Valiant Laboratories Ltd. 52 Week High Streak has continued for its second straight session, with the stock moving 2.78% across the streak and trading close to its 52-week peak again. Valiant Laboratories Ltd. (VALIANTLAB) is last trading at Rs 126 after touching Rs 127.65 in the day, and the latest market data confirms the repeated-near-high pattern but does not establish a company-specific catalyst for the move.

As of 21 September 2026 at 3:18 PM IST, Valiant Laboratories Ltd. was trading above the previous close of Rs 124.71 after opening at Rs 123.9 and touching a low of Rs 119. Turnover stood at Rs 0.5 crore and market capitalisation at Rs 677.33 crore. For readers tracking Valiant Laboratories Ltd. 52 Week High Streak, the key point is not just the day move, but the fact that the stock has stayed near the yearly high across multiple sessions rather than on a single burst.

Valiant Laboratories Ltd. 52 Week High Streak: Consecutive High Analysis

Valiant Laboratories Ltd. (VALIANTLAB) traded at Rs 126 versus the previous close of Rs 124.71, a rise of 1.03%. The stock opened at Rs 123.9, reached a high of Rs 127.65 and touched a low of Rs 119.

Valiant Laboratories Ltd. share price today was last trading at Rs 126, which is Rs 1.29 or 1.03% above the previous close of Rs 124.71. The stock opened at Rs 123.9, touched a high of Rs 127.65 and a low of Rs 119, placing the current quote in the upper half of the day’s range. That matters for readers following the Valiant Laboratories Ltd. 52 Week High Streak, because the stock has remained close to its 52-week peak while also holding above the prior session’s reference price.

Turnover for the session stood at Rs 0.5 crore, while market capitalisation was Rs 677.33 crore. The latest Valiant Laboratories Ltd. Share Price move fits the broader pattern of repeated trading near the one-year high, rather than a one-session spike. The current setup is therefore best read as a continuing near-high phase in the Valiant Laboratories Ltd. Stock News flow, with the price action still being monitored against its recent range and the streak now extending into a second straight session.

What the Repeated 52-Week Highs Show

The repeated near-high pattern suggests that Valiant Laboratories Ltd. has kept trading within 2% of its 52-week high for a second straight session, and the cumulative move across that stretch is 2.78%. That is the most useful headline for tracking the Valiant Laboratories Ltd. 52 Week High Streak, because it captures the full multi-session behaviour instead of just the latest quote. The latest numbers confirm a sustained proximity to the one-year peak, but they do not confirm any company-specific event behind it.

For a reader, the important distinction is between a one-day visit to a yearly high and a repeated pattern of trading near that level. The first can be momentary. The second shows that the stock has stayed close to the upper end of its recent trading band across consecutive sessions. In that sense, the Valiant Laboratories Ltd. Back To Back 52 Week Highs theme is about persistence, not just speed, and it is one reason the stock now appears in the broader set of Stocks Hitting 52 Week Highs.

Valiant Laboratories Ltd. (VALIANTLAB) Fundamental Analysis

Valiant Laboratories Ltd. (VALIANTLAB) fundamental metrics show P/E 42.32x, P/B 2.04x, ROE -0.93%, ROCE -0.4%. These figures provide context only and are not a buy or sell signal.

Valiant Laboratories Ltd. has a market capitalisation of Rs 677.33 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.32x, P/B at 2.04x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -0.93% and ROCE of -0.4%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.95, book value per share of Rs 61.13, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.19x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Valiant Laboratories Ltd. (VALIANTLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Valiant Laboratories Ltd. (VALIANTLAB) has a P/E ratio of 42.32x, which is above the benchmark median of 28.19x, a difference of +50.12%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Valiant Laboratories Ltd. (VALIANTLAB) has a ROE of -0.93%, which is below the benchmark median of 11.7%, a difference of -107.95%. Valiant Laboratories Ltd. (VALIANTLAB) has a ROCE of -0.4%, which is below the benchmark median of 13.61%, a difference of -102.94%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Valiant Laboratories Ltd. (VALIANTLAB) has a P/E ratio of 42.32x compared with the displayed peer median of 50.04x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.93% compares with a peer median of 12.26% across the companies shown in the table. ROCE stood at -0.4% versus the displayed peer median of 11.87%, providing a capital-efficiency comparison. Valiant Laboratories Ltd. (VALIANTLAB) has a market capitalisation of Rs 677.33 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Valiant Laboratories Ltd.

• The stock has now traded within 2% of its 52-week high for a second straight session.
• The cumulative move across the streak stands at 2.78%.
• The current quote of Rs 126 remains near the one-year high band.
• The P/E ratio of 42.32 is above the industry median of 28.19.
• ROE at -0.93% and ROCE at -0.4% keep the fundamental lens relevant.

About Valiant Laboratories Ltd.

Valiant Laboratories Ltd. is listed on NSE and BSE in the Pharmaceuticals & Drugs industry within Healthcare. The company’s latest profile shows a market capitalisation of Rs 677.33 crore, with a P/B of 2.04, EPS of Rs 2.95 and book value of Rs 61.13. For readers following Valiant Laboratories Ltd. Share Price trends, the stock’s current interest comes from its repeated trade near the yearly high rather than from a single isolated session.

The company’s recent valuation and profitability mix shows why investors often track both price behaviour and company financials together. In the current Valiant Laboratories Ltd. Stock Analysis, the market is still pricing the business at a premium to the industry median earnings multiple, while return ratios remain weak. That combination keeps the stock in focus for Valiant Laboratories Ltd. Company News and broader Stock Performance screens.

Track Valiant Laboratories Ltd. on Univest

Follow Valiant Laboratories Ltd. 52 Week High Streak updates on Univest to monitor fresh price moves, valuation context and company news in one place. The stock page on Univest also helps readers compare the latest quote, market capitalisation and peer snapshot as the streak evolves.

What does Valiant Laboratories Ltd. 52 Week High Streak mean?

It means Valiant Laboratories Ltd. has traded within 2% of its 52-week high for consecutive sessions. In this case, the streak has reached a second straight session, which keeps the stock in the near-one-year-high zone.

How many sessions has Valiant Laboratories Ltd. stayed near its 52-week high?

According to the latest Univest figures, Valiant Laboratories Ltd. has stayed within 2% of its 52-week high for two consecutive sessions. That is why the current event is described as a second straight session near the peak.

What is the cumulative move across the Valiant Laboratories Ltd. streak?

The cumulative streak move is 2.78%. This figure covers the full two-session near-high stretch and is more useful than focusing only on the latest day’s change.

Is Valiant Laboratories Ltd. at a new all-time high?

No. The event being tracked here is a 52-week high streak, not an all-time high. The latest numbers confirm proximity to the yearly peak, but they do not establish a record-high event.

What is Valiant Laboratories Ltd. trading at today?

Valiant Laboratories Ltd. was last trading at Rs 126, after opening at Rs 123.9 and touching Rs 127.65 intraday. The stock was above its previous close of Rs 124.71 at the latest reading.

How is Valiant Laboratories Ltd. valued versus peers?

The stock’s P/E ratio of 42.32 is above the industry median of 28.19, while its P/B ratio of 2.04 is below the industry median of 3.08. That creates a mixed valuation picture against the peer set.

What do Valiant Laboratories Ltd. financial ratios show?

ROE is -0.93% and ROCE is -0.4%, so the latest profitability and capital-return profile remains weak. EPS is Rs 2.95 and book value is Rs 61.13, which gives context to the current valuation.

Should investors track Valiant Laboratories Ltd. breakout levels now?

Investors tracking the stock can watch whether it keeps trading near the one-year peak and whether the valuation gap versus peers narrows or widens. The latest data confirms the pattern, but not a company-specific reason behind it.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).